InsiderTrades.com logo
The Next Step of Their Control Is Here …
From Weiss Ratings   |   Ad
Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.
4 simple steps to protect your privacy and money before it’s too late.

SLRN Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $23,698,008.00
Insider Selling (Last 12 Months): $198,547.91

Acelyrin Insider Trading History Chart

This chart shows the insider buying and selling history at Acelyrin by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Acelyrin Share Price & Price History

Current Price: $4.24
Price Change: +0.30 (1.20%)
As of 04/26/2024 01:00 AM ET

This chart shows the closing price history over time for SLRN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Protect Yourself While There’s Still Time …
From Weiss Ratings   |   Ad
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
4 simple steps to protect your privacy and money before it’s too late.

Acelyrin Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/20/2024Shao-Lee LinCEOSell15,701$7.60$119,327.601,587,335View SEC Filing Icon  
1/2/2024Shao-Lee LinCEOSell10,691$7.41$79,220.311,603,036View SEC Filing Icon  
5/9/2023Beth C SeidenbergDirectorBuy60,000$18.00$1,080,000.0060,000View SEC Filing Icon  
5/9/2023Biopartners Fund Ii WestlakeMajor ShareholderBuy1,250,000$18.00$22,500,000.009,790,729View SEC Filing Icon  
5/9/2023Mardi DierCFOBuy5,556$18.00$100,008.005,556View SEC Filing Icon  
5/9/2023Ronald OystonInsiderBuy1,000$18.00$18,000.001,000View SEC Filing Icon  
See Full Table
Protect Yourself While There’s Still Time …
From Weiss Ratings   |   Ad
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
4 simple steps to protect your privacy and money before it’s too late.

SEC Filings (Institutional Ownership Changes) for Acelyrin (NASDAQ:SLRN)

87.31% of Acelyrin stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SLRN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Acelyrin Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/14/2024Point72 Europe London LLP122,971$0.92M0.1%N/A0.126%Search for SEC Filing on Google Icon
2/14/2024Superstring Capital Management LP356,924$2.66M1.9%N/A0.367%Search for SEC Filing on Google Icon
2/14/2024Lighthouse Investment Partners LLC86,651$0.65M0.0%N/A0.089%Search for SEC Filing on Google Icon
2/14/2024Sectoral Asset Management Inc.325,549$2.43M1.0%N/A0.334%Search for SEC Filing on Google Icon
2/12/2024Capstone Investment Advisors LLC27,345$0.20M0.0%N/A0.028%Search for SEC Filing on Google Icon
2/12/2024Decheng Capital LLC1,370,951$10.23M2.9%N/A1.408%Search for SEC Filing on Google Icon
2/9/2024Dynamic Technology Lab Private Ltd14,431$0.11M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC49,500$0.37M0.0%+152.7%0.051%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank38,300$0.29M0.0%-40.2%0.039%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund13,181$98K0.0%+84.4%0.014%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank 10,716$80K0.0%+608.3%0.011%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio42,300$0.32M0.0%+504.3%0.043%Search for SEC Filing on Google Icon
1/30/2024Vontobel Holding Ltd.325,549$2.43M0.0%N/A0.334%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.17,038$0.13M0.0%-15.6%0.018%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.11,259$84K0.0%N/A0.012%Search for SEC Filing on Google Icon
1/16/2024Raymond James & Associates10,522$78K0.0%-43.3%0.011%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC14,741$0.11M0.0%N/A0.015%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.3,189,027$32.43M0.0%+3.8%3.276%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.73,269$0.75M0.0%N/A0.075%Search for SEC Filing on Google Icon
11/29/2023Decheng Capital Management III Cayman LLC1,548,317$15.75M4.0%-0.4%1.591%Search for SEC Filing on Google Icon
11/21/2023Walleye Capital LLC447,355$4.55M0.0%N/A0.460%Search for SEC Filing on Google Icon
11/15/2023Kynam Capital Management LP1,200,000$12.20M2.0%N/A1.233%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.100,000$1.02M0.0%-73.0%0.103%Search for SEC Filing on Google Icon
11/14/2023venBio Partners LLC3,852,470$39.18M11.1%-0.1%3.962%Search for SEC Filing on Google Icon
11/14/2023Schonfeld Strategic Advisors LLC202,662$2.06M0.0%+267.1%0.208%Search for SEC Filing on Google Icon
11/14/2023Fred Alger Management LLC53,206$0.54M0.0%-94.7%0.055%Search for SEC Filing on Google Icon
11/14/2023Profund Advisors LLC29,232$0.30M0.0%N/A0.030%Search for SEC Filing on Google Icon
11/13/2023Eagle Asset Management Inc.358,363$3.65M0.0%-31.1%0.369%Search for SEC Filing on Google Icon
11/13/2023CHI Advisors LLC2,262,990$23.02M6.9%-15.0%2.327%Search for SEC Filing on Google Icon
11/13/2023FMR LLC8,961,726$89.91M0.0%+20.2%9.216%Search for SEC Filing on Google Icon
11/13/2023Rafferty Asset Management LLC173,696$1.77M0.0%N/A0.179%Search for SEC Filing on Google Icon
11/9/2023Citigroup Inc.73,269$0.75M0.0%N/A0.075%Search for SEC Filing on Google Icon
11/8/2023Ausdal Financial Partners Inc.21,000$0.21M0.0%N/A0.022%Search for SEC Filing on Google Icon
11/8/2023Swiss National Bank64,100$0.65M0.0%N/A0.066%Search for SEC Filing on Google Icon
11/8/2023Amalgamated Bank4,281$44K0.0%N/A0.004%Search for SEC Filing on Google Icon
11/7/2023New York State Common Retirement Fund7,149$73K0.0%N/A0.007%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC106,688$1.08M0.0%N/A0.110%Search for SEC Filing on Google Icon
11/7/2023Jump Financial LLC19,592$0.20M0.0%-17.3%0.020%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc75,164$0.76M0.0%+22.0%0.077%Search for SEC Filing on Google Icon
10/26/2023Mirae Asset Global Investments Co. Ltd.20,196$0.21M0.0%N/A0.021%Search for SEC Filing on Google Icon
10/26/2023Strs Ohio7,000$71K0.0%N/A0.007%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp92,701$0.94M0.0%+601.1%0.095%Search for SEC Filing on Google Icon
10/24/2023Raymond James & Associates18,556$0.19M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/24/2023Perceptive Advisors LLC200,000$4.18M0.1%N/A0.206%Search for SEC Filing on Google Icon
8/22/2023CHI Advisors LLC2,663,806$55.67M16.8%N/A2.739%Search for SEC Filing on Google Icon
8/15/2023Braidwell LP500,000$10.45M0.3%N/A0.514%Search for SEC Filing on Google Icon
8/14/2023Samsara BioCapital LLC2,256,022$47.15M8.3%N/A2.321%Search for SEC Filing on Google Icon
8/14/2023Marshall Wace LLP1,161,528$24.28M0.0%N/A1.195%Search for SEC Filing on Google Icon
8/14/2023Rock Springs Capital Management LP141,876$2.97M0.1%N/A0.146%Search for SEC Filing on Google Icon
8/14/2023Driehaus Capital Management LLC1,758,797$36.76M0.5%N/A1.809%Search for SEC Filing on Google Icon
8/14/2023Ghisallo Capital Management LLC70,000$1.46M0.2%N/A0.072%Search for SEC Filing on Google Icon
8/11/2023AyurMaya Capital Management Company LP9,334,735$195.10M100.0%N/A9.604%Search for SEC Filing on Google Icon
8/11/2023General Atlantic L.P.1,500,000$31.35M0.5%N/A1.543%Search for SEC Filing on Google Icon
8/11/2023Sectoral Asset Management Inc.201,017$4.20M0.7%N/A0.207%Search for SEC Filing on Google Icon
8/11/2023Landscape Capital Management L.L.C.15,426$0.32M0.0%N/A0.016%Search for SEC Filing on Google Icon
8/11/2023Franklin Resources Inc.879,268$18.38M0.0%N/A0.905%Search for SEC Filing on Google Icon
8/11/2023Artal Group S.A.1,821,214$38.06M1.2%N/A1.874%Search for SEC Filing on Google Icon
8/11/2023JPMorgan Chase & Co.3,703,338$77.40M0.0%N/A3.810%Search for SEC Filing on Google Icon
8/11/2023ExodusPoint Capital Management LP111,077$2.32M0.0%N/A0.114%Search for SEC Filing on Google Icon
8/9/2023TD Asset Management Inc61,610$1.29M0.0%N/A0.063%Search for SEC Filing on Google Icon
8/3/2023Jennison Associates LLC200,000$4.18M0.0%N/A0.206%Search for SEC Filing on Google Icon
8/2/2023Bank of Montreal Can93,315$1.85M0.0%N/A0.096%Search for SEC Filing on Google Icon
7/28/2023Decheng Capital Management III Cayman LLC1,554,417$32.49M10.2%N/A1.599%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Acelyrin logo
Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, as well as in Phase 2 clinical trials for use in the treatment of Axial Spondyloarthritis. It is also developing lonigutamab, a humanized immunoglobulin G1 (IgG1) monoclonal antibody against insulin-like growth factor 1 receptor, which is in Phase 1 clinical trials for use in the treatment of thyroid eye disease; and SLRN-517, a fully human IgG1 monoclonal antibody targeting c-KIT, which is in preclinical stage for use in the treatment of chronic urticaria. The company was incorporated in 2020 and is headquartered in Agoura Hills, California.
Read More on Acelyrin

Today's Range

Now: $4.24
Low: $4.19
High: $4.34

50 Day Range

MA: $6.95
Low: $4.24
High: $8.63

52 Week Range

Now: $4.24
Low: $4.18
High: $29.88

Volume

654,242 shs

Average Volume

1,205,328 shs

Market Capitalization

$419.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Acelyrin?

Acelyrin's top insider investors include:
  1. Biopartners Fund Ii Westlake (Major Shareholder)
  2. Shao-Lee Lin (CEO)
  3. Beth C Seidenberg (Director)
  4. Mardi Dier (CFO)
  5. Ronald Oyston (Insider)
Learn More about top insider investors at Acelyrin.
The Next Step of Their Control Is Here …
From Weiss Ratings   |   Ad
Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.
4 simple steps to protect your privacy and money before it’s too late.